Not by a policy failure, not by a domestic crisis — by the fact, he said this week, that President Donald Trump backed Israel in a war against Iran. It’s in line with a grievance the podcaster and ...
TORONTO — Health Canada has approved the first needle-free epinephrine treatment for severe allergic reactions: a nasal spray called neffy. ALK Canada, which purchased the rights to distribute the ...
The Trump administration is pushing countries around the world to sign a joint declaration that calls for “trade over aid” and explicitly rejects America’s history as a leading provider of ...
ABSTRACT: Background: Anaphylaxis is a rapid, life-threatening allergic reaction requiring immediate intervention. In school settings where children with diverse allergies are present, school health ...
A year after the Trump administration began the dismantlement of USAID, it is initiating a new round of significant cuts to foreign assistance. This time, programs that survived the initial purge ...
Foreign aid spending is back in the U.S. government's budget, after a year in which the Trump administration cut billions of dollars to global health and humanitarian assistance. On Tuesday evening, ...
Last summer, the Dalai Lama was having a party in Dharamshala for his 90th birthday, and Bethany Morrison, a newly appointed State Department official, was eager to meet with him there. Inconveniently ...
The FDA has delayed approval of Aquestive Therapeutics’ new drug application seeking approval of Anaphylm, a sublingual epinephrine film for the treatment of Type 1 allergic reactions, including ...
neffy is the first epinephrine product approved for use out of a hospital setting in China for adults and children (>30 kg) living with severe allergic reactions Pediatrix Therapeutics, which has a ...
Three G protein–coupled receptors, the cysteinyl leukotriene receptors 1, 2, and 3 (CysLTR1, CysLTR2, and CysLTR3), mediate the effects of the cysteinyl leukotrienes in vivo. (Each receptor has a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results